A strategy towards the generation of testable adverse outcome pathways for nanomaterials.
- DOI
- 10.14573/altex.2102191
- Published
- 2021
- Container
- ALTEX
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.14573/altex.2102191,
title = {A strategy towards the generation of testable adverse outcome pathways for nanomaterials.},
author = {Murugadoss S and Vinković Vrček I and Pem B and Jagiello K and Judzinska B and Sosnowska A and Martens M and Willighagen EL and Puzyn T and Dusinska M and Cimpan MR and Fessard V and Hoet PH},
year = {2021},
journal = {ALTEX},
doi = {10.14573/altex.2102191},
url = {https://doi.org/10.14573/altex.2102191}
}RIS
TY - JOUR TI - A strategy towards the generation of testable adverse outcome pathways for nanomaterials. AU - Murugadoss S AU - Vinković Vrček I AU - Pem B AU - Jagiello K AU - Judzinska B AU - Sosnowska A AU - Martens M AU - Willighagen EL AU - Puzyn T AU - Dusinska M AU - Cimpan MR AU - Fessard V AU - Hoet PH PY - 2021 JO - ALTEX DO - 10.14573/altex.2102191 UR - https://doi.org/10.14573/altex.2102191 ER -
APA
S, M., I, V. V., B, P., K, J., B, J., A, S., M, M., EL, W., T, P., M, D., MR, C., V, F., & PH, H. (2021). A strategy towards the generation of testable adverse outcome pathways for nanomaterials.. ALTEX. https://doi.org/10.14573/altex.2102191
Source records
- pubmed · retrieved 2026-09-24T18:26:28.226Z